Michel Mittelbronn Selected Research

Disease Progression

1/2019	Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas.
9/2013	YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michel Mittelbronn Research Topics

Disease

86	Neoplasms (Cancer) 04/2024 - 06/2005
54	Glioblastoma (Glioblastoma Multiforme) 02/2022 - 06/2005
50	Glioma (Gliomas) 10/2021 - 05/2005
16	Brain Neoplasms (Brain Tumor) 03/2024 - 04/2005
15	Hypoxia (Hypoxemia) 10/2020 - 01/2007
15	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 04/2005
10	Neoplasm Metastasis (Metastasis) 10/2019 - 01/2011
9	Inflammation (Inflammations) 07/2023 - 06/2008
7	Parkinson Disease (Parkinson's Disease) 06/2023 - 02/2008
7	Melanoma (Melanoma, Malignant) 01/2023 - 01/2011
6	Stroke (Strokes) 03/2017 - 12/2008
6	Myocardial Ischemia (Ischemic Heart Diseases) 08/2015 - 03/2007
6	Ischemia 03/2013 - 03/2007
5	Oligodendroglioma 01/2016 - 11/2011
4	Necrosis 12/2023 - 06/2012
4	Dementia (Dementias) 06/2023 - 02/2008
4	Neuroinflammatory Diseases 01/2022 - 09/2013
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 11/2005
4	Neurilemmoma (Schwannoma) 01/2020 - 09/2014
4	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 03/2017 - 08/2007
4	Primitive Neuroectodermal Tumors (PNET) 01/2016 - 05/2011
4	Infarction (Infarctions) 08/2015 - 03/2007
4	Medulloblastoma 11/2014 - 05/2011
3	Meningioma (Meningiomas) 03/2024 - 01/2013
3	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2023 - 01/2022
3	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2013
3	Testicular Neoplasms (Testicular Cancer) 01/2021 - 03/2016
3	Neuroblastoma 01/2017 - 11/2014
3	Carcinogenesis 07/2016 - 01/2011
3	Reperfusion Injury 03/2013 - 10/2007
3	Gliosis 01/2013 - 07/2008
2	Infections 07/2023 - 01/2020
2	Nervous System Diseases (Neurological Disorders) 01/2023 - 05/2016
2	Ataxia (Dyssynergia) 01/2021 - 02/2010
2	Carcinoma (Carcinomatosis) 10/2020 - 01/2013
2	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 01/2020
2	Edema (Dropsy) 01/2020 - 03/2017
2	Ganglion Cysts (Ganglion) 01/2020 - 01/2004
2	Brain Edema (Cerebral Edema) 01/2020 - 05/2016

Drug/Important Bio-Agent (IBA)

43	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2005
14	Bevacizumab (Avastin)FDA Link 01/2021 - 10/2013
11	Biomarkers (Surrogate Marker)IBA 12/2023 - 09/2013
11	CytokinesIBA 07/2023 - 08/2007
11	EnzymesIBA 01/2023 - 08/2008
11	Messenger RNA (mRNA)IBA 01/2019 - 06/2005
9	Small Interfering RNA (siRNA)IBA 03/2019 - 06/2005
8	Temozolomide (Temodar)FDA LinkGeneric 04/2024 - 05/2011
8	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 03/2007
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 10/2008
8	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 02/2009
7	Transcription Factors (Transcription Factor)IBA 07/2022 - 01/2007
6	AntibodiesIBA 01/2021 - 01/2004
6	LigandsIBA 05/2019 - 09/2006
5	Phosphotransferases (Kinase)IBA 01/2020 - 12/2010
5	Mechanistic Target of Rapamycin Complex 1IBA 01/2019 - 01/2015
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 07/2012
5	Lactic Acid (Lactate)FDA LinkGeneric 09/2017 - 07/2005
4	ParaffinIBA 03/2024 - 07/2008
4	Formaldehyde (Formol)FDA Link 03/2024 - 01/2021
4	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2017
4	alpha-SynucleinIBA 01/2023 - 02/2008
4	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 01/2012
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2021 - 11/2011
4	viscum album peptide (Iscador)IBA 01/2019 - 01/2012
4	Glial Fibrillary Acidic ProteinIBA 09/2018 - 05/2012
4	Transforming Growth Factor beta (TGF-beta)IBA 08/2009 - 09/2006
3	SynucleinsIBA 06/2023 - 01/2022
3	IntegrinsIBA 01/2023 - 01/2013
3	Growth Differentiation Factor 15IBA 01/2023 - 08/2010
3	Lactate Dehydrogenase 5IBA 01/2021 - 10/2015
3	Alkylating AgentsIBA 12/2020 - 02/2008
3	Monoclonal AntibodiesIBA 10/2020 - 01/2008
3	Viscum ribosome inactivating proteinIBA 01/2019 - 02/2017
3	TOR Serine-Threonine KinasesIBA 01/2019 - 01/2015
3	Carboxypeptidase H (Carboxypeptidase E)IBA 09/2017 - 07/2012
3	LectinsIBA 02/2017 - 04/2007
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2017 - 08/2010
3	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 03/2013
3	AntigensIBA 11/2014 - 01/2004
3	Metalloproteases (Metalloproteinases)IBA 02/2013 - 09/2006
3	Oxygen (Dioxygen)IBA 07/2012 - 03/2007
3	5'-Nucleotidase (5' Nucleotidase)IBA 08/2008 - 03/2007
3	Aquaporins (Water Channels)IBA 06/2007 - 04/2005
2	Glutathione (Reduced Glutathione)IBA 07/2023 - 01/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022 - 10/2017
2	Mitochondrial DNA (mtDNA)IBA 01/2022 - 12/2013
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2016
2	Protein AggregatesIBA 01/2022 - 01/2016
2	InterleukinsIBA 01/2022 - 11/2015
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2021 - 01/2013
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 04/2009
2	ErbB Receptors (EGF Receptor)IBA 10/2020 - 10/2017
2	Beclin-1IBA 01/2020 - 04/2016
2	Cholinergic Agents (Cholinergics)IBA 01/2020 - 01/2004

Therapy/Procedure

40	Therapeutics 01/2023 - 03/2007
7	Drug Therapy (Chemotherapy) 01/2020 - 02/2008
7	Radiotherapy 01/2019 - 10/2007
4	Chemoradiotherapy 01/2016 - 04/2010
3	Immunotherapy 01/2023 - 06/2018
2	Lasers (Laser) 01/2023 - 10/2017